Literature DB >> 25973584

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.

Michael A Weber1, Ajay Kirtane2, Laura Mauri3, Raymond R Townsend4, David E Kandzari5, Martin B Leon2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25973584      PMCID： PMC8032088          DOI： 10.1111/jch.12590

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  15 in total

1.  Splanchnicectomy for essential hypertension; results in 1,266 cases.

Authors:  R H SMITHWICK; J E THOMPSON
Journal:  J Am Med Assoc       Date:  1953-08-15

2.  Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study.

Authors:  Daniel S Atherton; Nicholas L Deep; Farrell O Mendelsohn
Journal:  Clin Anat       Date:  2011-10-04       Impact factor: 2.414

Review 3.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

4.  Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Authors:  Michel Azizi; Marc Sapoval; Philippe Gosse; Matthieu Monge; Guillaume Bobrie; Pascal Delsart; Marco Midulla; Claire Mounier-Véhier; Pierre-Yves Courand; Pierre Lantelme; Thierry Denolle; Caroline Dourmap-Collas; Hervé Trillaud; Helena Pereira; Pierre-François Plouin; Gilles Chatellier
Journal:  Lancet       Date:  2015-01-26       Impact factor: 79.321

5.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Authors:  David E Kandzari; Deepak L Bhatt; Sandeep Brar; Chandan M Devireddy; Murray Esler; Martin Fahy; John M Flack; Barry T Katzen; Janice Lea; David P Lee; Martin B Leon; Adrian Ma; Joseph Massaro; Laura Mauri; Suzanne Oparil; William W O'Neill; Manesh R Patel; Krishna Rocha-Singh; Paul A Sobotka; Laura Svetkey; Raymond R Townsend; George L Bakris
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

7.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

8.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

9.  24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.

Authors:  Y Lacourcière; N Crikelair; R D Glazer; J Yen; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-01-20       Impact factor: 3.012

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  5 in total

1.  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?

Authors:  Michael Doumas; Konstantinos Stavropoulos; Konstantinos P Imprialos; Vasilios G Athyros; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-25       Impact factor: 3.738

2.  American Society of Hypertension Scientific Statements Addressing Resistant Hypertension.

Authors:  J Rick Turner; John Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-14       Impact factor: 3.738

3.  Renal denervation in hypertensive patients not on blood pressure lowering drugs.

Authors:  Rosa L De Jager; Margreet F Sanders; Michiel L Bots; Melvin D Lobo; Sebastian Ewen; Martine M A Beeftink; Michael Böhm; Joost Daemen; Oliver Dörr; Dagmara Hering; Felix Mahfoud; Holger Nef; Christian Ott; Manish Saxena; Roland E Schmieder; Markus P Schlaich; Wilko Spiering; Pim A L Tonino; Willemien L Verloop; Eva E Vink; Evert-Jan Vonken; Michiel Voskuil; Stephen G Worthley; Peter J Blankestijn
Journal:  Clin Res Cardiol       Date:  2016-04-22       Impact factor: 5.460

Review 4.  Interventional procedures and future drug therapy for hypertension.

Authors:  Melvin D Lobo; Paul A Sobotka; Atul Pathak
Journal:  Eur Heart J       Date:  2017-04-14       Impact factor: 29.983

Review 5.  Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade.

Authors:  Marco Antônio Peliky Fontes; Lucas Alexandre Santos Marzano; Carina Cunha Silva; Ana Cristina Simões E Silva
Journal:  J Bras Nefrol       Date:  2020-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.